QCM
RARE icon

Quantinno Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Quantinno Capital Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.93M Buy
187,508
+137,758
+277% +$3.1M 0.01% 1257
2025
Q4 		$1.14M Buy
49,750
+11,245
+29% +$370K ﹤0.01% 1697
2025
Q3 		$1.16M Buy
+38,505
New +$1.15M ﹤0.01% 1415
2025
Q1 		– Sell
-5,013
Closed -$211K – 2136
2024
Q4 		$211K Buy
+5,013
New +$249K ﹤0.01% 1523

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Quantinno Capital Management's RARE Position: Q1 2026 in Review

Quantinno Capital Management increased its Ultragenyx Pharmaceutical (RARE) stake by 277% in Q1 2026, buying an estimated $3.1M and bringing the position to 187,508 shares worth $3.93M. The position accounts for 0.01% of the portfolio, ranked #1257.

Quantinno Capital Management first reported a position in RARE in Q4 2024 and has held it in 4 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Quantinno Capital Management held 187,508 shares of Ultragenyx Pharmaceutical worth $3.93M as of Q1 2026.
  • Quantinno Capital Management bought 137,758 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $3.1M.
  • Ultragenyx Pharmaceutical made up 0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1257 holding.
  • Quantinno Capital Management first reported a position in Ultragenyx Pharmaceutical in Q4 2024 and has held it in 4 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.